```html

Uterine Embolism – Comprehensive Medical Guide

Overview

Uterine embolism (also called uterine artery embolism or uterine infarction) is a rare, acute blockage of the blood vessels that supply the uterus. The blockage is usually caused by a clot, fat, air, or other material that travels through the bloodstream and lodges in a uterine artery or its branches, cutting off oxygen and nutrients to uterine tissue.

Because the uterus is a highly vascular organ, a sudden loss of blood flow can lead to rapid tissue damage, severe pelvic pain, and potentially life‑threatening hemorrhage. The condition most commonly occurs in women of reproductive age (15‑45 years), but cases have been reported in post‑menopausal women and, rarely, in adolescent girls.

Uterine embolism is extremely uncommon. Large population studies from the United States estimate an incidence of ≈0.02 cases per 10 000 women per year (CDC). Most data come from case reports and small case series, which underscores the need for heightened clinical awareness.

Symptoms

Symptoms usually develop suddenly and can range from mild discomfort to severe, life‑threatening pain. Common presentations include:

• Acute pelvic or lower‑abdominal pain – often described as “sharp” or “cramping” and may radiate to the back or thighs.
• Vaginal bleeding – ranging from spotting to heavy menstrual‑like flow; in some cases, bright‑red arterial bleeding may occur.
• Sudden onset of uterine tenderness on bimanual examination.
• Nausea or vomiting – secondary to severe pain.
• Fever or chills – may signal secondary infection or tissue necrosis.
• Signs of anemia – fatigue, dizziness, pallor, especially if bleeding is substantial.
• Abnormal uterine discharge – serosanguinous or purulent if tissue necrosis leads to infection.
• Pelvic mass or uterine enlargement on physical exam or imaging, caused by edema or hematoma.

Causes and Risk Factors

Uterine embolism is generally the result of an embolic event, but several underlying mechanisms and risk factors have been identified:

Primary Causes

• Thromboembolism – blood clots arising from deep‑vein thrombosis (DVT), atrial fibrillation, or hypercoagulable states can travel to uterine arteries.
• Fat embolism – commonly after long‑bone fractures or orthopedic surgery; fat droplets may lodge in uterine vessels.
• Air embolism – rare, can occur during certain gynecologic procedures (e.g., hysteroscopy) if air is introduced.
• Amniotic‑fluid embolism – during labor or delivery, amniotic debris can enter maternal circulation and block uterine vessels.
• Tumor emboli – malignant cells from uterine or extra‑uterine tumors may obstruct arterial flow.

Risk Factors

• History of deep‑vein thrombosis, pulmonary embolism, or known hypercoagulable disorders (e.g., Factor V Leiden, antiphospholipid syndrome).
• Recent major surgery or trauma, especially orthopedic procedures.
• Use of estrogen‑containing contraceptives or hormone replacement therapy, which increase clotting risk.
• Pregnancy, especially in the third trimester, due to physiological hypercoagulability.
• Underlying cancer, particularly gynecologic malignancies that can shed tumor emboli.
• Smoking, obesity, and sedentary lifestyle, which contribute to venous stasis.
• Inherited or acquired vascular anomalies (e.g., uterine artery aneurysm) that predispose to embolic occlusion.

Diagnosis

Because uterine embolism mimics other gynecologic emergencies (e.g., ovarian torsion, ruptured ectopic pregnancy), a systematic approach is essential.

Clinical Evaluation

• Detailed history focusing on recent surgery, trauma, pregnancy, clotting disorders, and medication use.
• Comprehensive physical exam with bimanual pelvic assessment.

Imaging Studies

• Transvaginal pelvic ultrasound – First‑line; may show decreased uterine perfusion, heterogeneous myometrial echotexture, or a focal hypoechoic area.
• Color Doppler ultrasound – Demonstrates absent or markedly reduced arterial flow in the affected uterine artery.
• Contrast‑enhanced CT or MRI – Provides detailed anatomy, identifies infarcted tissue, and rules out other intra‑abdominal pathology.
• CT angiography (CTA) – Ideal for visualizing the exact site of arterial occlusion and planning possible endovascular intervention.

Laboratory Tests

• Complete blood count (CBC) – to assess anemia and leukocytosis.
• Coagulation profile (PT/INR, aPTT) and D‑dimer – to evaluate for hypercoagulability.
• Serum β‑hCG – to exclude pregnancy‑related emergencies.
• Blood cultures if infection is suspected.

Definitive Diagnosis

The diagnosis is confirmed when imaging demonstrates an occluded uterine artery with corresponding clinical findings. In ambiguous cases, digital subtraction angiography (DSA) may be performed, which also allows for simultaneous therapeutic embolization if indicated.

Treatment Options

Treatment aims to restore uterine perfusion (if possible), control pain and bleeding, prevent infection, and address the underlying cause of embolism.

Acute Medical Management

• Pain control – IV opioids (e.g., morphine) for severe pain; NSAIDs as adjuncts.
• Hemodynamic stabilization – IV fluids, packed red blood cell transfusion if hemoglobin < 7 g/dL or symptomatic.
• Anticoagulation – Intravenous unfractionated heparin (target aPTT 1.5‑2× control) is standard unless contraindicated (active bleeding).

Endovascular Intervention

When the embolus is accessible, catheter‑directed thrombolysis or mechanical thrombectomy can be performed via interventional radiology. In selected cases, uterine artery embolization (UAE) reversal using intra‑arterial thrombolytic agents (e.g., alteplase) has shown success in restoring flow.

Surgical Options

• Laparoscopic or open uterine artery ligation – Reserved for uncontrollable hemorrhage.
• Hysterectomy – Considered a last‑resort when uterine necrosis is extensive or infection cannot be contained.

Adjunctive Therapies

• Broad‑spectrum antibiotics if there is evidence of infection or after invasive procedures.
• Long‑term anticoagulation (warfarin, direct oral anticoagulants) for underlying hypercoagulable disorders, typically for 3‑6 months or longer per hematology recommendation.
• Hormonal modulation (e.g., GnRH agonists) may reduce uterine blood flow in chronic cases, though evidence is limited.

Lifestyle & Supportive Care

• Adequate hydration and gradual ambulation to prevent venous stasis.
• Compression stockings if DVT risk is high.
• Patient education about signs of re‑occlusion or bleeding.

Living with Uterine Embolism

Even after acute management, many women require ongoing care to preserve fertility, manage pain, and monitor for recurrence.

• Follow‑up imaging (Ultrasound or MRI) at 2‑4 weeks, then every 3‑6 months for the first year.
• Regular hematology reviews to adjust anticoagulation dosing and assess clotting status.
• Fertility counseling – If the uterus is viable, consultation with a reproductive specialist is advised before attempting conception.
• Pain management – Some women experience chronic pelvic pain; pelvic floor physical therapy or neuropathic pain agents (e.g., gabapentin) may be helpful.
• Emotional support – Experiencing a rare, potentially life‑threatening event can be traumatic; consider counseling or support groups.

Prevention

Because many risk factors are modifiable, preventive strategies focus on reducing embolic sources:

• Maintain a healthy weight and engage in regular aerobic activity to lower clot risk.
• Quit smoking; tobacco increases platelet aggregation.
• Use the lowest effective dose of estrogen‑containing contraceptives, or consider non‑estrogen options if clotting risk is high.
• Screen for and treat hypercoagulable disorders before pregnancy or major surgery.
• Follow peri‑operative anticoagulation protocols for patients undergoing orthopedic or major abdominal surgery.
• During obstetric procedures, ensure proper technique to avoid air entry and consider prophylactic anticoagulation in high‑risk pregnancies.

Complications

If left untreated or inadequately managed, uterine embolism can lead to serious outcomes:

• Uterine necrosis – irreversible tissue death, often requiring hysterectomy.
• Severe hemorrhage – can lead to hypovolemic shock.
• Infection/Sepsis – secondary to necrotic tissue.
• Infertility or compromised reproductive outcomes – especially if the endometrium is damaged.
• Chronic pelvic pain syndrome – may persist despite resolution of the embolus.
• Psychological sequelae – anxiety, depression, or post‑traumatic stress related to the acute event.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, peer‑reviewed articles in Obstetrics & Gynecology and Journal of Vascular Interventional Radiology (2020‑2024).

```